You have 9 free searches left this month | for more free features.

NRAS Mutant

Showing 1 - 25 of 711

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)

Not yet recruiting
  • Melanoma
  • tunlametinib
  • paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 15, 2023

Melanoma Trial in Beijing, Shanghai (HL-085)

Recruiting
  • Melanoma
  • Beijing, Beijing, China
  • +1 more
Dec 16, 2021

Melanoma Trial in Worldwide (Belvarafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Melanoma
  • Orange, California
  • +23 more
Aug 24, 2022

Recurrent Rectal Cancer, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer Trial in United States (trametinib, fluorouracil,

Active, not recruiting
  • Recurrent Rectal Cancer
  • +6 more
  • Saint Louis, Missouri
  • +3 more
Feb 15, 2022

Locally Advanced or Metastatic NRAS Mutant Melanoma Trial in Worldwide (LEE011, MEK162)

Completed
  • Locally Advanced or Metastatic NRAS Mutant Melanoma
  • San Francisco, California
  • +16 more
Nov 23, 2020

BRAF or NRAS Mutant Metastatic Melanoma Trial in Worldwide (MEK162)

Active, not recruiting
  • BRAF or NRAS Mutant Metastatic Melanoma
  • Fayetteville, Arkansas
  • +20 more
Nov 18, 2021

NSCLC, Melanoma Trial in Worldwide (LXH254, LTT462, Trametinib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Melanoma
  • San Diego, California
  • +31 more
Sep 12, 2022

Melanoma Trial in New York, Philadelphia (Trametinib daily Until PD, CDX-3379 (ERBB3 antibody))

Terminated
  • Melanoma
  • Trametinib daily Until PD
  • CDX-3379 (ERBB3 antibody)
  • New York, New York
  • +1 more
May 12, 2020

Solid Tumor Trial in Korea, Republic of (HM95573)

Completed
  • Solid Tumor
  • Cheongju, Chungcheongbuk-do, Korea, Republic of
  • +6 more
Aug 6, 2020

Metastatic Melanoma Trial in United States (IN10018, Cobimetinib)

Recruiting
  • Metastatic Melanoma
  • Miami, Florida
  • +4 more
Mar 29, 2022

Stage IV Melanoma, Stage III Melanoma Trial in Jette (Trametinib, Dabrafenib)

Recruiting
  • Stage IV Melanoma
  • Stage III Melanoma
  • Jette, Brussels, Belgium
    Universitair Ziekenhuis Brussel
Sep 29, 2021

Melanoma Trial in Beijing (FCN-159)

Recruiting
  • Melanoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Apr 28, 2019

Solid Tumours, Multiple Myeloma, Lung Cancer Trial in Sutton, London (VS-6766, Everolimus)

Recruiting
  • Solid Tumours
  • +2 more
  • Sutton, Surrey, United Kingdom
  • +1 more
Apr 25, 2022

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +3 more
  • Boston, Massachusetts
  • +9 more
Dec 22, 2022

Advanced Solid Tumor (Phase 1), Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) Trial in United States (IMM-1-104)

Recruiting
  • Advanced Solid Tumor (Phase 1)
  • +4 more
  • Duarte, California
  • +4 more
Feb 2, 2023

Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

Not yet recruiting
  • Malignant Solid Neoplasm
  • +4 more
  • (no location specified)
Nov 8, 2022

Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)

Not yet recruiting
  • Solid Tumors With HRAS Alterations
  • +4 more
  • (no location specified)
Aug 30, 2023

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Amsterdam (RMC-4630, LY3214996)

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • (no location specified)
Mar 9, 2022

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Colorectal Cancer, Pancreatic Cancer, Lung Cancer Trial in Brooklyn, New York (Vitamin C)

Recruiting
  • Colorectal Cancer
  • +2 more
  • Vitamin C
  • Brooklyn, New York
  • +1 more
Sep 22, 2021

Metastatic Colorectal Cancer Trial in United States (BAX69 + infusional 5-FU/LV, BAX69 + panitumumab, BAX69 + 5-FU/LV)

Terminated
  • Metastatic Colorectal Cancer
  • BAX69 + infusional 5-FU/LV
  • +3 more
  • Port Saint Lucie, Florida
  • +11 more
May 3, 2021

Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients

Recruiting
  • Melanoma (Skin)
  • +2 more
    • Evora, Portugal
      Hospital Evora
    May 30, 2022

    Ovarian Cancer Trial in Worldwide (Ipatasertib, Cobimetinib, Trastuzumab Emtansine)

    Recruiting
    • Ovarian Cancer
    • Tucson, Arizona
    • +60 more
    Jan 20, 2023

    Advanced Solid Tumors Trial in Cincinnati, Houston, Salt Lake City (YL-17231)

    Not yet recruiting
    • Advanced Solid Tumors
    • Cincinnati, Ohio
    • +2 more
    Oct 22, 2023

    Cancer, Malignancy, Neoplasia Trial in United States (ASN007: ascending doses, ASN007 RD)

    Completed
    • Cancer
    • +18 more
    • ASN007: ascending doses
    • ASN007 RD
    • Tampa, Florida
    • +4 more
    Jul 7, 2020